Signaling via dopamine D1 and D3 receptors oppositely regulates cocaine-induced structural remodeling of dendrites and spines

NeuroSignals

Volumn 20, Issue 1, 2012, Pages 15-34

  Zhang, Lei ^a   Li, Juan ^a   Liu, Nuyun ^a   Wang, Bin ^a   Gu, Jingjing ^a   Zhang, Min ^a   Zhou, Zhitao ^a   Jiang, Yong ^a   Zhang, Lin ^a   Zhang, Lu ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Cocaine; Dendrite; Dopamine receptors; Extracellular signal regulated kinase; Myocyte enhancer factor 2 activity; NMDA receptor; Signal transduction

Indexed keywords

COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 3 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MYOCYTE ENHANCER FACTOR 2; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CELL STRUCTURE; CONTROLLED STUDY; DENDRITE; DENDRITIC SPINE; ENZYME ACTIVATION; FEMALE; INTRACELLULAR SIGNALING; LONG TERM EXPOSURE; MALE; MOUSE; NEWBORN; NONHUMAN; NUCLEUS ACCUMBENS; PROTEIN PHOSPHORYLATION; PUTAMEN; RAT; REGULATORY MECHANISM; SYNAPSE;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; COCAINE; DENDRITES; DENDRITIC SPINES; FEMALE; MALE; MICE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D3; SIGNAL TRANSDUCTION;

EID: 84856042604     PISSN: 1424862X     EISSN: 14248638     Source Type: Journal    
DOI: 10.1159/000330743     Document Type: Article

References (95)

1. Koob GF, Sanna PP, Bloom FE: Neuroscience of addiction. Neuron 1998; 21:467-476. (Pubitemid 28475499)
2. White FJ, Kalivas PW: Neuroadaptations involved in amphetamine and cocaine addiction. Dr ug Alcohol Depend 1998; 51: 141-153. (Pubitemid 28353762)
3. Nestler EJ: Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2001; 2:119-128. (Pubitemid 33673366)
4. Hyman SE, Malenka RC: Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2001; 2: 695-703. (Pubitemid 33674815)
5. Laakso A, Mohn AR, Gainetdinov RR, Caron MG: Experimental genetic approaches to addiction. Neuron 2002; 36:213-228. (Pubitemid 35217888)
6. Robinson TE, Gorny G, Mitton E, Kolb B: Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse 2001; 39:257-266. (Pubitemid 32099681)
7. Norrholm SD, Bibb JA, Nestler EJ, Ouimet CC, Taylor JR, Greengard P: Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5. Neuroscience 2003; 116: 19-22. (Pubitemid 36110427)
8. Lee KW, Kim Y, Kim AM, Helmin K, Nairn AC, Greengard P: Cocaine-induced dendritic spine formation in d1 and d2 dopamine receptor-containing medium spiny neurons in nucleus accumbens. Proc Natl Acad Sci USA 2006; 103:3399-3404. (Pubitemid 43346480)
9. Russo SJ, Wilkinson MB, Mazei-Robison MS, Dietz DM, Maze I, Krishnan V: Nuclear factor kappa B signaling regulates neuronal morphology and cocaine reward. J Neurosci 2009; 29: 3529-3537.
10. LaPlant Q, Vialou V, Covington HE 3rd, Dumitriu D, Feng J, Warren BL, Maze I, Dietz DM, Watts EL, Iñiguez SD, Koo JW, Mouzon E, Renthal W, Hollis F, Wang H, Noonan MA, Ren Y, Eisch AJ, Bolaños CA, Kabbaj M, Xiao G, Neve RL, Hurd YL, Oosting RS, Fan G, Morrison JH, Nestler EJ: Dnmt3a regulates emotional behavior and spine plasticity in the nucleus accumbens. Nat Neurosci 2010; 13: 1137-1143.
11. Maze I, Covington HE 3rd, Dietz DM, LaPlant Q, Renthal W, Russo SJ, Mechanic M, Mouzon E, Neve RL, Haggarty SJ, Ren Y, Sampath SC, Hurd YL, Greengard P, Tara-khovsky A, Schaefer A, Nestler EJ: Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science 2010; 327: 213-216.
12. Robinson TE, Kolb B: Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and pre-frontal cortex following repeated treatment with amphetamine or cocaine. Eur J Neuro-sci 1999; 11: 1598-1604. (Pubitemid 29192234)
13. Civelli O, Bunzow JR, Grandy DK: Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol 1993; 33:281-307. (Pubitemid 23116009)
14. Sibley DR, Monsma FJJ, Shen Y: Molecular neurobiology of dopaminergic receptors. Int Rev Neurobiol 1993; 35: 391-415.
15. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG: Dopamine receptors: from structure to function. Physiol Rev 1998; 78: 189-225. (Pubitemid 28070979)
16. Liu XY, Mao LM, Zhang GC, Papasian CJ, Fibuch EE, Lan HX Zhou HF, Xu M, Wang JQ: Activity-dependent modulation of lim-bic dopamine D3 receptors by CaMKII. Neuron 2009; 61:425-438.
17. Xu M, Koeltzow TE, Santiago GT, Moratalla R, Cooper DC, Hu XT, White NM, Graybiel AM, White FJ, Tonegawa S: Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 a nd D2 receptors. Neuron 1997; 19: 837-848. (Pubitemid 27471388)
18. Zhang L, Lou D, Jiao H, Zhang D, Wang X, Xia Y, Zhang J, Xu M: Cocaine-induced in-tracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors. J Neurosci 2004; 24:3344-3354. (Pubitemid 38451900)
19. Jiao HY, Zhang L, Gao F, Lou D, Zhang J, Xu M: Dopamine D(1) and D(3) receptors oppositely regulate NMDA-and cocaine-induced MAPK signaling via NMDA receptor phos-phorylation. J Neurochem 2007; 103:840-848. (Pubitemid 47498042)
20. Berhow MT, Hiroi N, Nestler EJ: Regulation of ERK (extracellular signal regulated ki-nase), part of the neurotrophin signal trans-duction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J Neurosci 1996; 16: 4707-4715. (Pubitemid 26251066)
21. Valjent E, Corvol JC, Pages C, Besson MJ, Maldonado R, Caboche J: Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J Neurosci 2000; 20:8701-8709.
22. Choe ES, Chung KT, Mao L, Wang JQ: Amphetamine increases phosphorylation of extracellular signal-regulated kinase and transcription factors in the rat striatum via group I metabotropic glutamate receptors. Neuro-psychopharmacolog y 2002; 27: 565-575.
23. Mazzucchelli C, Vantaggiato C, Ciamei A, Fasano S, Pakhotin P, Krezel W, Welzl H, Wolfer DP, Pagès G, Valverde O, Marowsky A, Porrazzo A, Orban PC, Maldonado R, Eh-rengruber MU, Cestari V, Lipp HP, Chapman PF, Pouysségur J, Brambilla R: Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates stri-atal-mediated learning and memory. Neuron 2002; 34: 807-820. (Pubitemid 34628742)
24. Dudman JT, Eaton ME, Rajadhyaksha A, Macías W, Taher M, Barczak A, Kameyama K, Huganir R, Konradi C: Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1. J Neurochem 2003; 87:922-934. (Pubitemid 37444568)
25. Valjent E, Pascoli V, Svenningsson P, Paul S, Enslen H, Corvol JC, Stipanovich A, Cabo-che J, Lombroso PJ, Nairn AC, Greengard P, Hervé D, Girault JA: Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc Natl Acad Sci USA 2005; 102: 491-496. (Pubitemid 40116794)
26. Liu NY, Zhang L, Zhang L, Wang X: Dopamine D3 receptors mediated jak2 and GABAAa1 gene expression induced by cocaine. Chin Med J (Engl) 2007; 120:910-914. (Pubitemid 46845933)
27. Lee KW, Kim Y, Kim AM, Helmin K, Nairn AC, Greengard P: Cocaine-induced dendritic spine formation in D1 and D2 dopamine receptor-containing medium spiny neurons in nucleus accumbens. Proc Natl Acad Sci USA 2006; 103:3399-3404. (Pubitemid 43346480)
28. Pulipparacharuvil S, Renthal W, Hale CF, Taniguchi M, Xiao G, Kumar A, Russo SJ, Sikder D, Dewey CM, Davis MM, Greengard P, Nairn AC, Nestler EJ, Cowan CW: Cocaine regulates MEF2 to control synaptic and behavioral plasticity. Neuron 2008; 59: 621-633.
29. Shang H, Wei H, Yue B, Xu P, Huang H: Mi-crosatellite analysis in two populations of Kunming mice. Lab Anim 2009; 43: 34-40.
30. Zhang D, Zhang L, Tang Y, Zhang Q, Lou D, Sharp FR, Zhang J, Xu M: Repeated cocaine administration induces gene expression changes through the dopamine D1 receptors. Neuropsychopharmacology 2005; 30: 1443-1454. (Pubitemid 41153116)
31. Zhang D, Zhang L, Lou DW, Nakabeppu Y, Zhang J, Xu M: The dopamine D1 receptor is a critical mediator for cocaine-induced gene expression. J Neurochem 2002;82:1453-1464.
32. Xi ZX, Gardner EL: Pharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addiction. CNS Drug Rev 2007; 13: 240-259. (Pubitemid 47052351)
33. Zhang J, Zhang L, Jiao H, Zhang Q, Zhang D, Lou D, Katz JL, Xu M: c-fos facilitates the acquisition and extinction of cocaine-induced persistent changes. J Neurosci 2006; 26: 13287-13296. (Pubitemid 46011639)
34. Wolf ME, Jeziorski M: Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res 1993; 613:291-294. (Pubitemid 23179983)
35. Xi ZX, Newman AH, Gilbert JG, Pak AC, Peng XQ, Ashby CR Jr, Gitajn L, Gardner EL: The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats. Neuropsychopharmacology 2006; 31: 1393-1405.
36. Pritchard LM, Newman AH, McNamara RK, Logue AD, Taylor B, Welge JA, Xu M, Zhang J, Richtand NM: The dopamine D3 receptor antagonist NGB 2904 increases spontaneous and amphetamine-stimulated locomotion. Pharmacol Biochem Behav 2007; 86: 718-726. (Pubitemid 46829327)
37. Robinson, TE, Kolb B: Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neu-rosci 1997; 17:8491-8497. (Pubitemid 27461070)
38. Flores, C, Wen, X, Labelle-Dumais, C, and Kolb, B: Chronic phencyclidine treatment increases dendritic spine density in prefron-tal cortex and nucleus accumbens neurons. Synapse 2007; 61:978-984. (Pubitemid 350271777)
39. Robinson TE and Kolb B: Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and pre-frontal cortex following repeated treatment with amphetamine or cocaine. Eur J Neuro-sci 1999; 11: 1598-1604. (Pubitemid 29192234)
40. Li J, Guo Y, Schroeder FA, Youngs RM, Schmidt TW, Ferris C K onradi C, Akbarian S: Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling. J Neurochem 2004; 90:1117-1131. (Pubitemid 39167345)
41. Norrholm SD, Bibb JA, Nestler EJ, Ouimet CC, Taylor JR, Greengard P: Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5. Neuroscience 2003; 116: 19-22. (Pubitemid 36110427)
42. Meng Y, Zhang Y, Tregoubov V, Janus C, Cruz L, Jackson M, Lu WY, MacDonald JF, Wang JY, Falls DL, Jia Z: Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice. Neuron 2002; 35: 121-133. (Pubitemid 34804327)
43. Antonopoulos J, Dori I, Dinopoulos A, Chiotelli M, Parnavelas JG: Postnatal development of t he do paminergic system of the stria-tum in the rat. Neuroscience 2002; 110:245-256. (Pubitemid 34214943)
44. Gao, C, Wolf, ME: Dopamine receptors regulate NMDA receptor surface expression in prefrontal cortex neurons. J Neurochem 2008; 106:2489-2501.
45. Sun X, Milovanovic M, Zhao Y, Wolf ME: Acute and chronic dopamine receptor stimulation modulates AMPA receptor trafficking in nucleus accumbens neurons cocul-tured with prefrontal cortex neurons. J Neu-rosci 2008; 28:4216-4230.
46. McCroskery S, Bailey A, Lin L, Daniels MP: Transmembrane agrin regulates dendritic filopodia and synapse formation in mature hippocampal neuron cultures. Neuroscience 2009; 16 3: 16 8-17 9.
47. Richtand NM: Behavioral sensitization, alternative splicing, and D3 dopamine receptor-mediated inhibitory function. Neuro-psychopharmacology 2006; 31:2368-2375. (Pubitemid 44607053)
48. Yuan J., Chen X, Brodbeck R, Primus R, Braun J, Wasley JW, Thurkauf A: NGB 2904 and NGB 2849: two highly selective dopa-mine D3 receptor antagonists. Bioorg Med Chem Lett 1998; 8:2715-2718. (Pubitemid 28496658)
49. Newman AH, Cao J, Bennett CJ, Robarge MJ, Freeman RA, Luedtke RR: N-(4-4-(2,3-dichlorophenyl)piperazin-1-ylbutyl, bute-nyl and butynyl)arylcarboxamides as novel dopamine D(3) receptor antagonists. Bioorg Med Chem Lett 2003; 13: 2179-2183. (Pubitemid 36694300)
50. Morrow BA, Hajszan T, Leranth C, Elsworth JD, Roth RH: Prenatal exposure to cocaine is associated with increased number of spine synapses in rat prelimbic cortex. Synapse 2007; 61:862-865. (Pubitemid 47328805)
51. Nikonenko I, Jourdain P, Alberi S, Toni N, Muller D: Activity-induced changes of spine morpholog y. Hippocampus 2002; 12: 585-591.
52. Wong RO, Ghosh A: Activity-dependent regulation of dendritic growth and patterning. Nat Rev Neurosci 2002; 3:803-812. (Pubitemid 135706691)
53. Tolias K F, Bikoff JB, Burette A, Paradis S, Harrar D, Tavazoie S, Weinberg RJ, Green-berg ME: The Rac1-GEF Tiam1 couples the NMDA receptor to the activity-dependent development of dendritic arbors and spines. Neuron 2005; 45: 525-538. (Pubitemid 40249865)
54. Espinosa JS, Wheeler DG, Tsien RW, Luo L: Uncoupling dendrite growth and patterning: single-cell knockout analysis of NMDA receptor 2B. Neuron 2009; 62: 205-217.
55. Karler R, Calder LD, Bedingfield JB: Cocaine behavioral sensitization and the excitatory amino acids. Psychopharmacology 1994; 11 5: 305-310. (Pubitemid 24217088)
56. Kim HS, Park WK, Jang CG, Oh S: Inhibition by MK-801 of cocaine-induced sensitization, conditioned place preference, and dopa-mine-receptor supersensitivity in mice. Brain Res Bull 1996; 40:201-207. (Pubitemid 26167299)
57. Li Y, Hu X-T, Berney TG, Vartanian AJ, Stine CD, Wolf ME, White FJ: Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitiza-tion and associated neuroadaptations. Synapse 1999; 34: 169-180. (Pubitemid 29508592)
58. Lyons GE, Micales BK, Schwarz J, Martin JF, Olson EN: Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. J Neurosci 1995; 15: 5727-5738.
59. Moratalla R, Elibol B, Vallejo M, Graybiel AM: Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron 1996; 17:147-156. (Pubitemid 26251599)
60. Kiraly DD, Ma XM, Mazzone CM, Xin X, Mains RE, Eipper BA: Behavioral and morphological responses to cocaine require kali-rin7. Biol Psychiatry 2010; 68:249-255.
61. Kopec CD, Li B, Wei W, Boehm J, Malinow R: Glutamate receptor exocytosis and spine enlargement during chemically induced long-term potentiat ion. J Neurosci 2006; 26: 2000-2009.
62. Xie Z, Srivastava DP, Photowala H, Kai L, Cahill ME, Woolfrey KM, Shum CY, Sur-meier DJ, Penzes P: Kalirin-7 controls activity-dependent structural and functional plasticity of dendritic spines. Neuron 2007; 56: 640-656. (Pubitemid 350102031)
63. Surmeier DJ, Song WJ, Yan Z: Coordinated expression of dopamine receptors in neo-striatal medium spiny neurons. J Neurosci 1996; 16: 6579-6591. (Pubitemid 26337379)
64. Rid ray S, Grif fon N, Mig non V, Soui l E, Car-boni S, Diaz J, Schwartz JC, Sokoloff P: Co-e x pre s sion of do p a m i ne D1 a nd D3 recep tor s in islands of Calleja and shell of nucleus ac-cumbens of the rat: opposite and synergistic functional interactions. Eur J Neurosci 1998; 10:1676-1686. (Pubitemid 28327315)
65. Ingham CA, Hood SH, Taggart P, Arbuth-nott GW: Plasticity of synapses in the rat neostriatum after unilateral lesion of the ni-grostriatal dopaminergic pathway. J Neuro-sci 1998; 18: 4732-4743. (Pubitemid 28280181)
66. Greenough WT, Bailey CH: The anatomy of a memory: convergence of results across a diversity of tests. Trends. Neurosci 1988; 11:142-147.
67. Kolb B, Whishaw IQ: Brain plasticity and behavior. Annu Rev Psychol 1998; 49:43-64. (Pubitemid 128491767)
68. Robinson TE, Kolb B: Structural plasticity associated with exposure to drugs of abuse. Neuropharmacolog y 2004; 47(suppl 1):33-46. (Pubitemid 39298251)
69. Battisti JJ, Shreffler CB, Uretsky NJ, Wallace LJ: NMDA antagonists block expression of sensitization of amphetamine-and apomor-phine-induced stereotypy. Pharmacol Bio-chem Behav 2000; 67:241-246. (Pubitemid 32000829)
70. Druhan JP, Wilent WB: Effects of the competitive N-methyl-D-aspartate receptor antagonist, CPP, on the development and expression of conditioned hyperactivity and sensitization induced by cocaine. Behav Brain Res 1999; 102: 195-210. (Pubitemid 29314580)
71. Uzbay IT, Wallis CJ, Lal H, Forster MJ: Effects of NMDA receptor blockers on cocaine-stimulated locomotor activity in mice. Behav Bra in Res 2000; 108: 57-61. (Pubitemid 30009727)
72. Konradi C, Leveque JC, Hyman SE: Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J Neurosci 1996; 16:4231-4239. (Pubitemid 26192418)
73. Lee FJ, Xue S, Pei L, Vukusic B, Chéry N, Wang Y, Wang YT, Niznik HB, Yu XM, Liu F: Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor. Cell 2002; 111:219-230. (Pubitemid 35292442)
74. XY, Chu XP, Mao LM, Wang M, Lan HX, Li MH, Zhang GC, Parelkar NK, Fibuch EE, Haines M, Neve KA, Liu F, Xiong ZG, Wang JQ: Modulation of D2R-NR2B interactions i n re s p onse to coc a i ne. Ne u ron 2 0 0 6; 52:897-909. (Pubitemid 44828444)
75. Cepeda C, Levine MS: Where do you think you are going? The NMDA-D1 receptor trap. Sci STKE 2006; 333:pe20.
76. Kruse MS, Prémont J, Krebs MO, Jay TM: Interaction of dopamine D1 with NMDA NR1 receptors in rat prefrontal cortex. Eur Neu-ropsychopharmacol 2009; 19: 296-304.
77. Lee DK, Bian S, Rahman MA, Shim YB, Shim I, Choe ES: Repeated cocaine administration increases N-met hyl-D-aspartate NR1 subunit, extracellular signal-regulated ki-nase and cyclic AMP response element-binding protein phosphorylation and gluta-mate release in the rat dorsal striatum. Eur J Pharmacol 2008; 59 0: 157-162.
78. Tingley WG, Ehlers MD, Kameyama K, Doherty C, Ptak JB, Riley CT, Huganir RL: Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies. J Biol Chem 1997; 272: 51 5 7-516 6. (Pubitemid 27090073)
79. Sesack SR, Carr DB, Omelchenko N, Pinto A: Anatomical substrates for glutamate-dopa-mine interactions: evidence for specificity of connections and extrasynaptic actions. Ann NY Acad Sci 2003; 1003:36-52. (Pubitemid 38083044)
80. Sun X, Z hao Y, Wolf M E: Dopa m i ne receptor stimulation modulates AMPA receptor syn-aptic insertion in prefrontal cortex neurons. J Neurosci 2005; 25:7342-7351. (Pubitemid 41129806)
81. Wolf ME, Mangiavacchi S, Sun X: Mechanisms by which dopamine receptors may influence synaptic plasticity. Ann NY Acad Sci 2003; 1003:241-249. (Pubitemid 38083060)
82. Segal M, Greenberger V, Korkotian E: Formation of dendritic spines in cultured stria-tal neurons depends on excitatory afferent act ivity. Eur J Neurosci 2003; 17: 2573-2585. (Pubitemid 36819282)
83. Alonso M, Medina JH, Pozzo-Miller: LERK1/2 activation is necessary for BDNF to increase dendritic spine density in hippo-campal CA1 pyramidal neurons. Learn Mem 2004; 11:172-178. (Pubitemid 38456599)
84. Lu L, Koya E, Zhai H, Hope BT, Shaham Y: Role of ERK in cocaine addiction. Trends Neurosci 20 06; 29: 695-703. (Pubitemid 44794537)
85. Girault JA, Valjent E, Caboche J, Hervé D: ERK2: a logical AND gate critical for drug-induced plasticity? Curr Opin Pharmacol 2007; 7:77-85. (Pubitemid 46238037)
86. Lee JH, Kim KT: Induction of cyclin-depen-dent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase A pathways during reti-noic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE (2) C cells. J Neurochem 2004; 91:634-647.
87. Fu WY, Chen Y, Sahin M, Zhao XS, Shi L, Bikoff JB Lai KO, Yung WH, Fu AK, Green-berg ME, Ip NY: Cdk5 regulates EphA4-me-diated dendritic spine retraction through an ephexin1-dependent mechanism. Nat Neu-rosci 2007; 10:67-76. (Pubitemid 46026529)
88. Lagace DC, Benavides DR, Kansy JW, Ma-pelli M, Greengard P, Bibb JA, Eisch AJ: Cdk5 is essential for adult hippocampal neu-rogenesis. Proc Natl Acad Sci USA 2008; 105: 18567-18571.
89. Zhang J, Cicero SA, Wang L, Romito-Digia-como RR, Yang Y, Herrup K: Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons. Proc Natl Acad Sci USA 2008; 105:8772-8777. (Pubitemid 351987755)
90. Lai KO, Ip NY: Recent advances in understanding the roles of Cdk5 in synaptic plasticity. Biochim Biophys Acta 2009; 1792:741-745.
91. Bibb JA, Chen J, Taylor JR, Svenningsson P, Nishi A, Snyder GL, Yan Z, Sagawa ZK, Oui-met CC, Nairn AC, Nestler EJ, Greengard P: Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 2001; 410: 376-380. (Pubitemid 32246055)
92. Flavell SW, Cowan CW, Kim TK, Greer PL, Lin Y, Paradis S, Griffith EC, Hu LS, Chen C, Greenberg ME: Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 2006; 311:1008-1012. (Pubitemid 43271729)
93. Shalizi A, Gaudillière B, Yuan Z, Stegmüller J, Shirogane T, Ge Q, Tan Y, Schulman B, Harper JW, Bonni A: A calcium-regulated MEF2 sumoylation switch controls postsyn-aptic differentiation. Science 2006; 311:1012-1017. (Pubitemid 43271730)
94. Harada T, Morooka T, Ogawa S, Nishida E: ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. Nat Cell Biol 2001; 3:453-459. (Pubitemid 32422080)
95. Ren Z, Sun WL, Jiao H, Zhang D, Kong H, Wang X, Xu M: Dopamine D1 and N-meth-yl-D-aspartate receptors and extracellular signal-regulated kinase mediate neuronal morphological changes induced by repeated cocaine administration. Neuroscience 2010; 16 8: 48-60.